CORC

浏览/检索结果: 共16条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Determining the optimal fasting glucose target for patients with type 2 diabetes: Results of the multicentre, open-label, randomized-controlled FPG GOAL trial 期刊论文
DIABETES OBESITY & METABOLISM, 2019, 卷号: 21, 期号: 8
作者:  Yang, Wenying;  Ma, Jianhua;  Yuan, Guoyue;  Li, Ling;  Zhang, Min
收藏  |  浏览/下载:19/0  |  提交时间:2019/12/05
CLINICAL STUDY ON THE TREATMENT OF ISLET B CELL FAILURE TYPE 2 DIABETES WITH INSULIN LYSINE COMBINED WITH INSULIN GLULISINE 期刊论文
ACTA MEDICA MEDITERRANEA, 2019, 卷号: 35, 期号: 4
作者:  Liu, Shufang;  Kong, Fanling;  Wang, Yi;  Zhang, Xiaoyong;  Gao, Xiaoli
收藏  |  浏览/下载:19/0  |  提交时间:2019/12/05
Determining the optimal fasting glucose target for patients with type 2 diabetes: Results of the multicentre, open-label, randomized-controlled FPG GOAL trial 期刊论文
DIABETES OBESITY & METABOLISM, 2019, 卷号: 21, 期号: 8, 页码: 1973-1977
作者:  Yang, Wenying[1];  Ma, Jianhua[2];  Yuan, Guoyue[3];  Li, Ling[4];  Zhang, Min[5]
收藏  |  浏览/下载:37/0  |  提交时间:2019/12/24
Liraglutide, Sitagliptin, and Insulin Glargine Added to Metformin: The Effect on Body Weight and Intrahepatic Lipid in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease 期刊论文
2019, 卷号: 69, 期号: 6, 页码: 2414-2426
作者:  Yan, Jinhua;  Yao, Bin;  Kuang, Hongyu;  Yang, Xubin;  Huang, Qin
收藏  |  浏览/下载:34/0  |  提交时间:2020/01/03
Cost-effectiveness of exenatide twice daily vs insulin glargine as add-on therapy to oral antidiabetic agents in patients with type 2 diabetes in China 期刊论文
DIABETES OBESITY & METABOLISM, 2017, 卷号: 19, 期号: 12, 页码: 1688-1697
作者:  Gu, Shuyan;  Wang, Xiaoyong;  Qiao, Qing;  Gao, Weiguo;  Wang, Jian
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/12
A reduced risk of hypoglycaemia with insulin degludec vs. insulin glargine U100 in Asian insulin-naive patients with T2D 期刊论文
DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 卷号: 120
作者:  Yang, Wenying;  Li, Qiang
收藏  |  浏览/下载:23/0  |  提交时间:2019/12/04
Insulin analogs detemir, glargine and lispro enhance proliferation of human thyroid and gastric normal or cancer cell lines 期刊论文
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 卷号: 9, 页码: 1603-1611
作者:  Cui, Wei;  Ji, Mei-Ju;  Chen, Huan;  Wang, Ning;  Zhao, Yu-Jing
收藏  |  浏览/下载:2/0  |  提交时间:2019/11/26
A randomised, open-labelstudy of insulin glargine or neutral protamine Hagedorn insulin in Chinese paediatric patients with type 1 diabetes mellitus 期刊论文
BMC ENDOCRINE DISORDERS, 2016, 卷号: 16
作者:  Liu, Min;  Zhou, Zhiguang;  Yan, Jinhua;  Li, Pin;  Song, Wenhui
收藏  |  浏览/下载:9/0  |  提交时间:2019/12/06
A randomised, open-labelstudy of insulin glargine or neutral protamine Hagedorn insulin in Chinese paediatric patients with type 1 diabetes mellitus 期刊论文
2016, 卷号: 16, 期号: 1, 页码: 67
作者:  Liu Min;  Zhou Zhiguang;  Yan Jinhua;  Li Pin;  Song Wenhui
收藏  |  浏览/下载:4/0  |  提交时间:2020/01/04
Glargine insulin/gliclazide MR combination therapy is more effective than premixed insulin monotherapy in Chinese patients with type 2 diabetes inadequately controlled on oral antidiabetic drugs.[Article] 期刊论文
Diabetes/Metabolism: Research & Reviews, 2015, 卷号: Vol.31 No.7, 页码: 725-733
作者:  Zhou, Jian 1;  Zheng, Fenping 2;  Guo, Xiaohui 3;  Yang, Huazhang 4;  Zhang, Muxun 5
收藏  |  浏览/下载:7/0  |  提交时间:2019/02/25


©版权所有 ©2017 CSpace - Powered by CSpace